Defining and describing the pre-dementia stages of familial Alzheimer's disease

Alzheimer's Research and Therapy

Volumn 3, Issue 5, 2011, Pages

  Ryan, Natalie S ^a   Rossor, Martin N ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; DEMENTIA; FAMILIAL ALZHEIMER DISEASE; HISTORY; NOMENCLATURE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW;

EID: 84867336407     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt91     Document Type: Review

References (15)

1. Early-stage and preclinical Alzheimer disease. JC Morris, Alzheimer Dis Assoc Disord 2005 19 163 165 10.1097/01.wad.0000184005.22611.cc 16118535
2. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. RJ Bateman, PS Aisen, B De Strooper, NC Fox, CA Lemere, JM Ringman, S Salloway, RA Sperling, M Windisch, C Xiong, Alzheimers Res Ther 2011 3 1 21211070
3. Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. EM Reiman, JB Langbaum, PN Tariot, Biomark Med 2010 4 3 14 10.2217/bmm.09.91 20383319
4. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study. N Acosta-Baena, D Sepulveda-Falla, CM Lopera-Gámez, MC Jaramillo-Elorza, S Moreno, DC Aguirre-Acevedo, A Saldarriaga, F Lopera, Lancet Neurol 2011 10 213 220 10.1016/S1474-4422(10)70323-9 21296022
5. Correlating familial Alzheimer's disease gene mutations with clinical phenotype. NS Ryan, MN Rossor, Biomark Med 2010 4 99 112 10.2217/bmm.09.92 20387306
6. Mild cognitive impairment: clinical characterization and outcome. RC Petersen, GE Smith, SC Waring, RJ Ivnik, EG Tangalos, E Kokmen, Arch Neurol 1999 56 303 308 10.1001/archneur.56.3.303 10190820
7. Mild cognitive impairment represents early-stage Alzheimer disease. JC Morris, M Storandt, JP Miller, DW McKeel, JL Price, EH Rubin, L Berg, Arch Neurol 2001 58 397 405 10.1001/archneur.58.3.397 11255443
8. The premild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease. B Reisberg, L Prichep, L Mosconi, ER John, L Glodzik-Sobanska, I Boksay, I Monteiro, C Torossian, A Vedvyas, N Ashraf, IA Jamil, MJ de Leon, Alzheimers Dement 2008 4 98 S108 10.1016/j.jalz.2007.11.017 18632010
9. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. NC Fox, EK Warrington, AL Seiffer, SK Agnew, MN Rossor, Brain 1998 121 Pt 9 1631 1639 9762953
10. Revising the definition of Alzheimer's disease: a new lexicon. B Dubois, HH Feldman, C Jacova, JL Cummings, ST Dekosky, P Barberger-Gateau, A Delacourte, G Frisoni, NC Fox, D Galasko, S Gauthier, H Hampel, GA Jicha, K Meguro, J O'Brien, F Pasquier, P Robert, M Rossor, S Salloway, M Sarazin, LC de Souza, Y Stern, PJ Visser, P Scheltens, Lancet Neurol 2010 9 1118 1127 10.1016/S1474-4422(10)70223-4 20934914
11. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. RA Sperling, PS Aisen, LA Beckett, DA Bennett, S Craft, AM Fagan, T Iwatsubo, CR Jack Jr, J Kaye, TJ Montine, DC Park, EM Reiman, CC Rowe, E Siemers, Y Stern, K Yaffe, MC Carrillo, B Thies, M Morrison-Bogorad, MV Wagster, CH Phelps, Alzheimers Dement 2011 7 280 292 10.1016/j.jalz.2011.03.003 21514248
12. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. MS Albert, ST DeKosky, D Dickson, B Dubois, HH Feldman, NC Fox, A Gamst, DM Holtzman, WJ Jagust, RC Petersen, PJ Snyder, MC Carrillo, B Thies, CH Phelps, Alzheimers Dement 2011 7 270 279 10.1016/j.jalz.2011.03.008 21514249
13. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. WE Klunk, JC Price, CA Mathis, ND Tsopelas, BJ Lopresti, SK Ziolko, W Bi, JA Hoge, AD Cohen, MD Ikonomovic, JA Saxton, BE Snitz, DA Pollen, M Moonis, CF Lippa, JM Swearer, KA Johnson, DM Rentz, AJ Fischman, HJ Aizenstein, ST DeKosky, J Neurosci 2007 27 6174 6184 10.1523/JNEUROSCI.0730-07.2007 17553989
14. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. NC Fox, EK Warrington, PA Freeborough, P Hartikainen, AM Kennedy, JM Stevens, MN Rossor, Brain 1996 119 Pt 6 2001 2007 9010004
15. Longitudinal change in CSF biomarkers in a presymptomatic carrier of an APP mutation. JM Ringman, K Taylor, E Teng, G Coppola, K Gylys, Neurology 2011 76 2124 2125 10.1212/WNL.0b013e31821f4488 21562250